The downregulation of the AT1 receptor together with increased tissue levels of Ang II, as well as increased angiotensin-converting enzyme (ACE) at both mRNA and protein levels in BPH [124,125], suggests that RAS activation in BPH depends on its cellular localization and function. Here, AGTR1 is linked to benign prostatic hyperplasia.